Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | FABP3 | P05413 | 7/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 3/20 | 0.39 |
| ▸ | CES1 | P23141 | 3/20 | 0.39 |
| ▸ | S1PR2 | O95136 | 3/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 3/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.39 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sebacic Acid SCHEMBL8648840 | 0.88 | CA1 (0.60) | CA1FABP3CES2CES1 | |
| Azelaic Acid SCHEMBL4377214 | 0.88 | CA1 (0.60) | CA1FABP3CES2CES1 | |
| Stearic Acid SCHEMBL900922 | 0.86 | FABP3 (0.60) | CA1FABP3CES2CES1 | |
| Tridecanoate SCHEMBL5459906 | 0.86 | FABP3 (0.60) | CA1FABP3CES2CES1 | |
| Myristic Acid SCHEMBL9245302 | 0.86 | FABP3 (0.60) | CA1FABP3CES2CES1 | |
| Palmitic Acid SCHEMBL2452648 | 0.86 | FABP3 (0.60) | CA1FABP3CES2CES1 | |
| Heptanoate SCHEMBL8361326 | 0.86 | FABP3 (0.60) | CA1FABP3CES2CES1 | |
| Dodecanoate SCHEMBL35315 | 0.86 | FABP3 (0.60) | CA1FABP3CES2CES1 | |
| Nonanoate SCHEMBL8365974 | 0.86 | FABP3 (0.60) | CA1FABP3CES2CES1 | |
| Dodecanoate SCHEMBL4869587 | 0.86 | FABP3 (0.60) | CA1FABP3CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113710718-B | Stabilized silane-modified polymer compositions and methods | 迈图高新材料公司 | 2024-06-25 | — | — | CN | claimed |
| EP-3956376-A1 | STABLE SILANE MODIFIED POLYMER COMPOSITION AND METHOD | Momentive Performance Materials Inc. (US) | 2022-02-23 | — | — | EP | claimed |
| WO-2020214935-A1 | STABILE SILANE MODIFIED POLYMER COMPOSITION AND METHOD | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2020-10-22 | — | — | WO | claimed |
| US-20200332052-A1 | STABILE SILANE MODIFIED POLYMER COMPOSITION AND METHOD | MOMENTIVE PERFORMANCE MATERIALS INC. | 2020-10-22 | — | — | US | claimed |
| US-12617891-B2 | Flexible foams comprising additives for improving hardness | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2026-05-05 | — | — | US | disclosed |
| CN-113710718-B | Stabilized silane-modified polymer compositions and methods | 迈图高新材料公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-118201974-A | Flexible foam comprising additives for increasing hardness | 迈图高新材料公司 | 2024-06-14 | — | — | CN | disclosed |
| EP-4377371-A1 | FLEXIBLE FOAMS COMPRISING ADDITIVES FOR IMPROVING HARDNESS | Momentive Performance Materials Inc. (US) | 2024-06-05 | — | — | EP | disclosed |
| US-11945899-B2 | Moisture-curable silylated resin derived from polycarbonate diol and coating, sealant and adhesive compositions containing same | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2024-04-02 | — | — | US | disclosed |
| US-11905428-B2 | Resin compositions and methods of production | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2024-02-20 | — | — | US | disclosed |
| EP-3448904-B1 | PROCESS FOR PRODUCING AN IMPROVED FLEXIBLE FOAM USING POLYMER POLYOLS PRODUCED VIA DMC CATALYZED POLYOLS | COVESTRO LLC (US) | 2024-01-31 | — | — | EP | disclosed |
| US-20230068883-A1 | A MOISTURE-CURABLE SILICONE ELASTOMER COMPOSITION | WACKER CHEMIE AG (DE) | 2023-03-02 | — | — | US | disclosed |
| EP-0005302-A2 | Impregnated porous granules with slow-release pore membranes, and process for the manufacture thereof | STAUFFER CHEMICAL COMPANY (US) | 1979-11-14 | — | — | EP | disclosed |
| US-4172825-A | Polymer/polyols and process for production thereof | UNION CARBIDE CORPORATION (US) | 1979-10-30 | — | — | US | disclosed |
| US-4162353-A | HALOPHOSPHATES OR POLYMERS THEREOF | UNION CARBIDE CORPORATION (US) | 1979-07-24 | — | — | US | disclosed |
| US-4148840-A | Polymer/polyol compositions made from preformed polymer/polyols, processes for making same and processes for making polyurethane products therefrom | UNION CARBIDE CORPORATION (US) | 1979-04-10 | — | — | US | disclosed |
| US-4143002-A | CHALK-RESISTANT, MEDIUM TO DARK COLORED POLYURETHANES, POLYMER/POLYOL AND POLYISOCYANATE COMPOSITIONS FOR USE IN PRODUCING SAME AND METHODS FOR MAKING SAID POLYURETHANES | UNION CARBIDE CORPORATION (US) | 1979-03-06 | — | — | US | disclosed |
| US-4119586-A | Polymer/polyol compositions, processes for making same and processes for making polyurethane products therefrom | UNION CARBIDE CORPORATION (US) | 1978-10-10 | — | — | US | disclosed |
| US-4018724-A | ZINC SALT OF 2-MERCAPTOBENZOTHIAZOLE | THE GENERAL TIRE & RUBBER COMPANY (US) | 1977-04-19 | — | — | US | disclosed |
| US-3978011-A | DISCOLORATION INHIBITION, ZINC SALT OF DITHIOCARBAMIC ACID | THE GENERAL TIRE & RUBBER COMPANY (US) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617891-B2 | Flexible foams comprising additives for improving hardness | SMC3, SMCHD1, SMC2 | CA1 2826/4885FABP3 2609/4885EPHX1 3944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.